Biogen Total Revenue from 2010 to 2026

IDP Stock  EUR 158.65  0.05  0.03%   
Biogen's Total Revenue is increasing over the last several years with very volatile swings. Total Revenue is predicted to flatten to about 9.1 B. Total Revenue is the total amount of income generated by the sale of goods or services related to Biogen's primary operations. View All Fundamentals
 
Total Revenue  
First Reported
2017-03-31
Previous Quarter
2.5 B
Current Value
2.3 B
Quarterly Volatility
463.5 M
 
Covid
 
Interest Hikes
Check Biogen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biogen's main balance sheet or income statement drivers, such as Interest Expense of 171.9 M, Selling General Administrative of 2.5 B or Total Revenue of 9.1 B, as well as many indicators such as . Biogen financial statements analysis is a perfect complement when working with Biogen Valuation or Volatility modules.
  
This module can also supplement various Biogen Technical models . Check out the analysis of Biogen Correlation against competitors.
The Total Revenue trend for Biogen Inc offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Biogen is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Biogen's Total Revenue Growth Pattern

Below is the plot of the Total Revenue of Biogen Inc over the last few years. Total revenue comprises all receipts Biogen Inc generated from the sale of its products or services. It is the total amount of income generated by the sale of goods or services related to the company's primary operations. Biogen's Total Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biogen's overall financial position and show how it may be relating to other accounts over time.
Total Revenue10 Years Trend
Very volatile
   Total Revenue   
       Timeline  

Biogen Total Revenue Regression Statistics

Arithmetic Mean10,817,868,235
Geometric Mean10,713,356,490
Coefficient Of Variation14.96
Mean Deviation1,302,657,716
Median9,890,600,000
Standard Deviation1,617,901,894
Sample Variance2617606.5T
Range5.3B
R-Value0.04
Mean Square Error2787424.9T
R-Squared0
Significance0.88
Slope13,129,363
Total Sum of Squares41881704.6T

Biogen Total Revenue History

20269.1 B
20259.9 B
20249.7 B
20239.8 B
202210.2 B
202111 B
202013.4 B

About Biogen Financial Statements

Biogen stakeholders use historical fundamental indicators, such as Biogen's Total Revenue, to determine how well the company is positioned to perform in the future. Although Biogen investors may analyze each financial statement separately, they are all interrelated. For example, changes in Biogen's assets and liabilities are reflected in the revenues and expenses on Biogen's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Biogen Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue9.9 B9.1 B

Currently Active Assets on Macroaxis

When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:
Check out the analysis of Biogen Correlation against competitors.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Biogen's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.